Reflux

Too Much Acid in Your Diet: It's Probably Your Coffee

Retrieved on: 
Mercoledì, Aprile 24, 2024
Coffee, A&T, NIH, University of California, Davis, Research, Acid, Bloating, NC A&T, Reflux, Critical, Heartburn, UC

This is important, as the high acid levels in regular coffee are now known to cause gut and other health problems.

Key Points: 
  • This is important, as the high acid levels in regular coffee are now known to cause gut and other health problems.
  • Coffee is a well-known source of acid and health problems; WebMD.com lists coffee as the leading cause of heartburn, and Leena Khaitan , MD states, "…the worst beverage for Acid Reflux is coffee".
  • Mislabeling by certain coffee brands claiming low acid is a growing concern, particularly in light of the serious health risks coming from high acid diets.
  • More on acid in coffee, and on Puroast verified low acid quality, and as an option to conventional high acid coffees, can be found at www.puroast.com .

New Study on the Current State of Health Care for Eosinophilic Esophagitis

Retrieved on: 
Giovedì, Maggio 18, 2023
Disease, Food, AAFA, Eosinophilic esophagitis, Regeneron Pharmaceuticals, Patient experience, Malnutrition, Weight loss, Life, Esophagus, Pollen, Chest pain, MBA, Research, Reflux, Eosinophil, Stomach, Vomiting, Asthma, Patient, Master of Science, Nausea, Diagnosis, United, German American Partnership Program, Mouth, Caregiver, Medical device, Nursing, Pharmaceutical industry, Sanofi

The results of the study portray the current state of EoE care in the United States and identify unmet needs for patients, family members, and health care providers.

Key Points: 
  • The results of the study portray the current state of EoE care in the United States and identify unmet needs for patients, family members, and health care providers.
  • Eosinophilic esophagitis (EoE) is a chronic inflammatory condition of the esophagus (the tube that connects the mouth to the stomach).
  • The study aimed to understand the patient journey for EoE as well as health care providers’ awareness of and practice around EoE.
  • Insights from patients, caregivers, and health care providers describe the current state of EoE care in the United States—including challenges and barriers to timely diagnosis, quality medical care, effective treatments, and access to resources for EoE.

Intoleran Differentiates Gluten and Fructan Intolerances

Retrieved on: 
Giovedì, Ottobre 6, 2022
Quality of life, Approximation error, Fructan, Lactose, Alpha-galactosidase, Diagnosis, Confusion, Sucrose, Triticale, Human, Immune system, Fructose, Degenerative disease, Food, Reflux, Galactose, Bloating, Flour, Dairy product

FORT LAUDERDALE, Fla., Oct. 6, 2022 /PRNewswire/ -- Everyone wants to say that they have a gluten intolerance. However, the dietary professionals at Intoleran have a solid argument that, more often than not, an intolerance to fructans is what is causing symptoms. It's the similarities in foods that contain gluten and fructans that makes the diagnosis difficult.

Key Points: 
  • Gluten is a protein that is found in various cereals, including wheat, barley, rye, and triticale.
  • "There's often a bit of confusion between gluten and fructans," explains Intoleran owner Harmen Treep, "Often eating grain products leads to an upset stomach or other digestional discomforts.
  • This is blamed on gluten, and if someone has celiac disease (meaning they're gluten intolerant), this is likely the culprit.
  • Intoleran products assist the digestive system by helping to properly digest food and, consequently, avoid many of the unpleasant side effects that come from food intolerances.

HTL Announces Its Incubator's Equity Investment In GelMEDIX, An Early-Stage Biotech Aiming At Revolutionizing Ocular And Regenerative Therapies

Retrieved on: 
Giovedì, Marzo 10, 2022
University, Heart, Cornea, Urology, 3D bioprinting, Allergic conjunctivitis, Birth, Tissue engineering, Biopolymer, Mechanics, Partnership, Research, Inflammation, Therapy, Orix USA, Cell, Dermatology, Investment, Gel, Health, UCLA, Osteoarthritis, HTL, Joint, DNA, Pain, Safar, Hyaluronic acid, Regenerative medicine, Patient, Glycosaminoglycan, Ophthalmology, Investor, Lubrication, Rheumatology, Reflux, Ear, Series, Glaucoma, Technology, Eye, Harvard Medical School, Harvard University, Knowledge, Peptide, Innovation, MIT, Biotechnology, Global health, Massachusetts Eye and Ear, Medicine, Duane syndrome, Viscosity, Pharmaceutical industry, Dentistry, Medical device, Professional services, Fine chemical

This investment supports continued development of the GelMEDIX platform, which enables the delivery of therapeutics from small molecules to cell and gene therapies.

Key Points: 
  • This investment supports continued development of the GelMEDIX platform, which enables the delivery of therapeutics from small molecules to cell and gene therapies.
  • Initial research focuses on ophthalmology with lead programs in vision restoring cornea and retina cell therapies and sustained release small molecule therapies.
  • GelMEDIX Inc. is an early-stage biotechnology company committed to innovating the next generation of ocular and regenerative therapies through its proprietary hydrogel platform.
  • Safar takes advantage of the principles of private equity to create value as our companies scale beyond initial prototypes.

RSIP Vision Presents New Technology for Intra-op Virtual Measurements in Laparoscopic and Robotic-Assisted Surgeries

Retrieved on: 
Martedì, Gennaio 25, 2022
Software, Other Health, Optical, Data Management, Oncology, Technology, Medical Devices, Hospitals, Surgery, Biotechnology, Nursing, Medical Supplies, Health, Medical device, Trauma, Malabsorption, Artificial intelligence, RSIP, Gastrectomy, Industry, Reflux, CA, Elective surgery, Software, Rambam Health Care Campus, Roux-en-Y anastomosis, Calibration, Multimedia, Ischemia, Hand, Bariatric surgery, Pylorus, Tissue, Technology, Bowel obstruction, Inflammation, Whipple, CEO, Medical imaging

Presently, Laparoscopic and Robotic Assisted Surgeries use a real-time video feed for guidance, which is not fully utilized, said Ron Soferman, CEO at RSIP Vision.

Key Points: 
  • Presently, Laparoscopic and Robotic Assisted Surgeries use a real-time video feed for guidance, which is not fully utilized, said Ron Soferman, CEO at RSIP Vision.
  • Leveraging RSIP Visions deep learning-based landmark detection technology, the tool tip is automatically tracked, enabling virtual measurements without introduction of a physical ruler into the scene.
  • RSIP Vision is driving innovation in Visual Intelligence for Medical Devices, through advanced AI and computer vision applications.
  • RSIP Vision is headquartered in Jerusalem, and has a U.S. office in San Jose, CA.

FDA grants Orphan Drug Designation in the US for CAM2029 for the treatment of polycystic liver disease

Retrieved on: 
Giovedì, Settembre 16, 2021
Somatostatin, GEP-NET, Liver, Patient, Quality of life, CAMX, Classification, Polycystic liver disease, Reflux, Camurus, Octreotide, CET, Infection, International, Abdominal pain, Degenerative disease, Acromegaly, Indigestion, Epidemiology, PLD, Growth, Addiction, International Association, Conditional sentence, Pain, Shortness of breath, Woman, Cancer, Nasdaq Stockholm, Breathe Me, Medical imaging

CAM2029 has been granted orphan designation in the EU for the treatment of acromegaly and in the US for the treatment of PLD.

Key Points: 
  • CAM2029 has been granted orphan designation in the EU for the treatment of acromegaly and in the US for the treatment of PLD.
  • Neijenhuis, M.K., et al., Impact of liver volume on polycystic liver disease-related symptoms and quality of life.
  • Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases.
  • Severity in polycystic liver disease is associated with aetiology and female gender: Results of the International PLD Registry.

FDA grants Orphan Drug Designation in the US for CAM2029 for the treatment of polycystic liver disease

Retrieved on: 
Giovedì, Settembre 16, 2021
Somatostatin, GEP-NET, Liver, Patient, Quality of life, CAMX, Classification, Polycystic liver disease, Reflux, Camurus, Octreotide, CET, Infection, International, Abdominal pain, Degenerative disease, Acromegaly, Indigestion, Epidemiology, PLD, Growth, Addiction, International Association, Conditional sentence, Pain, Shortness of breath, Woman, Cancer, Nasdaq Stockholm, Breathe Me, Medical imaging

CAM2029 has been granted orphan designation in the EU for the treatment of acromegaly and in the US for the treatment of PLD.

Key Points: 
  • CAM2029 has been granted orphan designation in the EU for the treatment of acromegaly and in the US for the treatment of PLD.
  • Neijenhuis, M.K., et al., Impact of liver volume on polycystic liver disease-related symptoms and quality of life.
  • Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases.
  • Severity in polycystic liver disease is associated with aetiology and female gender: Results of the International PLD Registry.

Global Esophageal Reflux Partnering Directory 2019

Retrieved on: 
Venerdì, Marzo 22, 2019
RTT, Chemistry, Esophageal cancer, Gastrointestinal cancer, Gastroesophageal reflux disease, Reflux

DUBLIN, March 22, 2019 /PRNewswire/ -- The "Global Esophageal Reflux Partnering 2014-2019" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 22, 2019 /PRNewswire/ -- The "Global Esophageal Reflux Partnering 2014-2019" report has been added to ResearchAndMarkets.com's offering.
  • The Global Esophageal Reflux Partnering Terms and Agreements since 2014 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.
  • Chapter 3 provides a comprehensive directory of partnering deals signed and announced since 2014.
  • Global Esophageal Reflux Partnering Terms and Agreements since 2014 report provides the reader with the following key benefits:
    Insight into key deal terms included in contracts, where disclosed
    Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

New Large-Scale Solvent Recycling Plant for Recovery of Large Quantities of Solvents

Retrieved on: 
Martedì, Maggio 1, 2018
Chemistry, Distillation, Laboratory techniques, Industrial processes, Unit operations, Reflux, Packed bed, Polyethylene terephthalate, Impurity, Air separation, Fractional distillation

The ASC-3000 separates valuable solvents from impurities such as water or other liquid chemicals by distillation in a highly automated 24-hour operation.

Key Points: 
  • The ASC-3000 separates valuable solvents from impurities such as water or other liquid chemicals by distillation in a highly automated 24-hour operation.
  • A packed column with automatic reflux is used to increase the separation efficiency.
  • The benefit of the plant is that the operator can carry out very economical treatment on his own premises, thereby saving high disposal and transport costs.
  • Depending on the substances or liquids and impurities to be separated, the plant can recover up to 10 tons of liquid recyclable material per day.